Usefulness of Diffusion-Weighted MRI for Differentiation between Parkinson’s Disease and Parkinson Variant of Multiple System Atrophy
Journal of Movement Disorders. 2009;2(2):64-68 
Serial MRI findings in a case of the Parkinson variant of multiple system atrophy: Clinical usefulness of diffusion-weighted imaging at B1000 in early stages of the disease
Journal of the Neurological Sciences. 2016;362:136-138
Usefulness of diffusion-tensor MRI in the diagnosis of Parkinson variant of multiple system atrophy and Parkinson's disease: a valuable tool to differentiate between them?
Clinical Radiology. 2017;72(7):610.e9-610.e15
Diffusion-weighted MRI distinguishes Parkinson disease from the parkinsonian variant of multiple system atrophy: A systematic review and meta-analysis
PLOS ONE. 2017;12(12):e0189897
Comparison of diffusion-weighted imaging and [123I]IBZM-SPECT for the differentiation of patients with the Parkinson variant of multiple system atrophy from those with Parkinson's disease
Movement Disorders. 2004;19(12):1438-1445
Differentiation of Parkinson’s disease and Parkinsonism predominant multiple system atrophy in early disease stages by means of objective measurement in Susceptibility Weighted Imaging
. 2021;
Voxelwise meta-analysis of gray matter anomalies in Parkinson variant of multiple system atrophy and Parkinson’s disease using anatomic likelihood estimation
Neuroscience Letters. 2015;587:79-86
Differences in early speech patterns between Parkinson variant of multiple system atrophy and Parkinson’s disease
Brain and Language. 2015;147:14-20
Diffusion tensor MRI for the differentiation of Parkinson's disease and multiple system atrophy
Nature Clinical Practice Neurology. 2007;3(10):544-545
Use of the Putamen/Caudate Volume Ratio for Early Differentiation between Parkinsonian Variant of Multiple System Atrophy and Parkinson Disease
Journal of Clinical Neurology. 2007;3(2):79